India  

‘Covaxin will also provide immunity against Covid mutants’: ICMR scientist

Video Credit: HT Digital Content - Duration: 04:36s - Published
‘Covaxin will also provide immunity against Covid mutants’: ICMR scientist

Covaxin will also provide immunity against Covid mutants’: ICMR scientist

Dr Samiran Panda, scientist, India Council of Medical Research (ICMR) said that Bharat Biotech’s Covaxin will also provide immunity against covid-19 mutants.

Panda added that India has taken a smart vaccination approach.

“Covaxin presents to the immune system a wide array of antigens,” said Panda.

He added, “The array of proteins and range of cells are the soldiers of immunity which will be developed following vaccination.

So that will be able to address the mutants as well.

I’m not tremendously worried and we don’t have any scientific evidence as yet that the mutants are going to challenge the efficacy of the vaccine.” Panda added, “Within 10-12 months, the vaccine has come out and this underlines the superiority, ability and the commitment of the scientists of India and I would say this is phenomenal.” Watch the full video for more.


You Might Like


💡 newsR Knowledge: Other News Mentions

Giant panda Giant panda Species of mammal

Panda takes first steps into the world [Video]

Panda takes first steps into the world

This is little Fan Xing's introduction to the world and he seems quite at homeat Ouwehands Zoo in the Netherlands. Since his birth on May 1 the young giantpanda stayed in the maternity pen with his mother Wu Wen. The 14kg cub sleepsfour fours between meals, followed by short and careful walks and longstretching exercises. Zoologist José Kok says: "As you could see, this isreally the moment that he starts to eat bamboo. In the beginning, it was onlynibbling on it and playing with it, but now you can see that he starts to eat,and we only know if he eats as soon as there are pieces of bamboo in his pooof course, we didn't see that yet, but I think it will happen not far fromhere." Fan Xing's parents went to the Netherlands in 2017 from the pandarescue centre in China. The bears were supposed to breed because there are notmany giant pandas left in the wild. "You know, we are very eager toparticipate in breeding programmes and especially for the giant panda becausethe giant panda is the symbol for threatened nature. So right from thebeginning, when we started this project, it was our aim to get the pandas hereand do the breeding. Yes, but when the pandas arrived here, mum and dad, theywere only three years old. So we had to wait another three years before theywere finally able to mate and get a cub," Kok says. The young panda's name FanXing refers to Van Gogh's painting Starry Night. Fan comes from Fan Gao, whichmeans Van Gogh in Chinese, while Xing, which means star, and symbolises hope,is also a reference to the panda's father Xing Ya, meaning Elegant Star. Themother's name Wu Wen means Beautiful Powerful Cloud. Giant pandas are solitaryanimals. The male panda Xing Ya lives in a separate enclosure. It took a lotof time and creativity to bring the two together to mate. Kok says: "We alwayssaid we prefer the natural way, and we saw right from the beginning when thefemale is in oestrus, we had them close to each other. Normally they liveapart, but when she was in distress we would have them a little bit closer toeach other, and we could see that, wow, they didn't hate each other, you know,and that was good news because if there was not this mix is good, good feelingbetween the two of them, you would never have a mating." Wu Wen now has atleast a few years of rest before another breeding attempt is made. In thewild, pandas do not often get pregnant, as the bears live solitary lives andfemales are only fertile for a few days each year. The Ouwehands zoo in Rheneis the only zoo in the Netherlands where visitors can see giant pandas. Thezoo and the Chinese panda rescue centre made the deal giving the panda'sfamily only a temporary home. Kok knows the panda's time is limited. She says:"Well, the cub Fan Fan Xing, he can stay here until he's four years old andthen he has to go back to China and really normally the cubs would stay withmum for about two years. So we have to see how the relationship between thesetwo develops. And definitely, we're going to get them together again foranother mating in the future." Wu Wen and Xing Ya will stay in the Netherlandsfor fifteen years.

Credit: PA - Press Association STUDIO    Duration: 01:10Published

Indian Council of Medical Research Indian Council of Medical Research

India records 10,064 new COVID cases in last 24 hours [Video]

India records 10,064 new COVID cases in last 24 hours

As per the data released by Ministry of Health and Family Welfare (MoHFW), India on January 19 reported single-day spike of 10,064 new coronavirus cases in the last 24 hours. 137 deaths in the same period pushed the COVID-19 toll in the country to 1,52,556. India's confirmed cases of coronavirus stand at 1,05,81,837 which include 2,00,528 active infections. More than 1,02,28,753 people have recovered from the virus with 17,411 new discharges in last 24 hours. According to Indian Council of Medical Research (ICMR), a total of 7,09,791 samples were tested on January 18. Cumulative samples tested for COVID-19 till January 18 are 18,78,02,827.

Credit: ANI    Duration: 01:12Published
India records 13,788 new COVID cases in last 24 hours [Video]

India records 13,788 new COVID cases in last 24 hours

As per the data released by Ministry of Health and Family Welfare (MoHFW), India on January 18 reported single-day spike of 13,788 new coronavirus cases in the last 24 hours. 145 deaths in the same period pushed the COVID-19 toll in the country to 1,52,419. India's confirmed cases of coronavirus stand at 1,05,71,773 which include 2,08,012 active infections. More than 1,02,11,342 people have recovered from the virus with 14,457 new discharges in last 24 hours. According to Indian Council of Medical Research (ICMR), a total of 5,48,168 samples were tested on January 17. Cumulative samples tested for COVID-19 till January 17 are 18,70,93,036.

Credit: ANI    Duration: 01:26Published
COVID-19: Total cases cross 1.05 crore-mark in India [Video]

COVID-19: Total cases cross 1.05 crore-mark in India

On January 16, total COVID-19 tally of India reached to 1,05,42,841. The country reported 15,158 new COVID-19 cases in last 24 hours and active cases stands at 2,11,033. With new 16,977 discharges, total number reached to 1,01,79715. 175 deaths were reported in last 24 hours, taking cumulative toll to 1,52,093. According to ICMR, total number of samples tested up to 11th January is 18,57,65,491 and of these, 8,03,090 samples were tested yesterday.

Credit: ANI    Duration: 01:52Published

BBV152 BBV152 Vaccine against COVID-19

‘Covid vaccines safe; politics on issue is unfortunate’: Health Minister [Video]

‘Covid vaccines safe; politics on issue is unfortunate’: Health Minister

Union Health minister Dr. Harsh Vardhan reiterated the two vaccines which have been granted approval for use in India are safe and effective. He added that some people are playing politics over the issue resulting in vaccine hesitancy among a section of the people. Harsh Vardhan said that the vaccines will be the last nail in the coffin of Covid. He also said that mild fever, pain and swelling are common after vaccination and added that very few people have shown these side-effects too. Questions have been raised about the safety of Covaxin which has not yet published any data from phase three clinical trials. Additionally, the government has also said that people will not get to choose a vaccine in the first phase. Watch the full video for all the details.

Credit: HT Digital Content    Duration: 03:11Published
Authorities to bear hospitalisation cost post Covaxin jab: Health Ministry [Video]

Authorities to bear hospitalisation cost post Covaxin jab: Health Ministry

Health and Family Welfare Ministry of India on January 19 said that in case of the Covaxin which has been given emergency use authorization under clinical trial mode (Covaxin), hospitalization cost would be borne by authorities. He said, "There are two vaccines. One of the two vaccines is given emergency use authorization under clinical trial mode. In a document for this vaccine, it's mentioned that if there's causal relation between immunization and adverse event weather it is severe or serious, hospitalization cost would be borne by authorities."

Credit: ANI    Duration: 01:30Published
Healthcare workers should be given choice in vaccines: Karnataka resident doctors [Video]

Healthcare workers should be given choice in vaccines: Karnataka resident doctors

Karnataka Association of Resident Doctors (KARD) has demanded the government to let people choose which COVID-19 vaccine, between Pune-based Serum Institute of India's Covishield and Hyderabad-based Bharat Biotech's Covaxin, they want to take. "Government of India has approved Covishield and Covaxin vaccines. We have all the reports for Covishield. But, Covaxin is still in phase-III trials, where the trial is being done on healthcare workers. We condemn this...Healthcare workers should be given a choice of vaccine," said Dr Dayanand Sagar. GoI rolled out COVID-19 vaccine jab from January 16.

Credit: ANI    Duration: 01:30Published

Coronavirus disease 2019 Coronavirus disease 2019 Disease caused by severe acute respiratory syndrome coronavirus 2

COVID-19 surge on Florida campuses inspires partnership to offer eligible teachers vaccine [Video]

COVID-19 surge on Florida campuses inspires partnership to offer eligible teachers vaccine

The COVID surge in Florida schools is prompting new pleas to the Governor and new action by local school districts desperate to keep teachers safe.

Credit: ABC Action News    Duration: 02:28Published
Fly high! Kashmiri girl masters sketching amid lockdown [Video]

Fly high! Kashmiri girl masters sketching amid lockdown

In the recent times, Kashmiri youth have chosen art to express their thoughts. A 19-year-old girl Ritambra from Kathua district has astounded everyone with her artwork. Without any guidance from teacher, Ritambra has mastered in sketching. Her constant source of encouragement has been her parents and sibling. During COVID induced lockdown, she got a chance to shine her art and now she has become a sensation. From former President APJ Abdul Kalam and PM Narendra Modi to sports and film celebrities, Ritambra has made portraits of several known personality. Ritambra's father Sukh Dev Singh wanted her to join a professional filed but after seeing his daughter's skills, Singh motivated and encouraged her to sharpen the art form. Ritambra has become an inspiration for girls sitting idle in their homes to come up with their talent and skill.

Credit: ANI    Duration: 03:43Published
Florida announces COVID-19 vaccination site at University Mall in Tampa [Video]

Florida announces COVID-19 vaccination site at University Mall in Tampa

The Florida Department of Health and Florida Division of Emergency Management announced a new state-supported COVID-19 vaccination site in Tampa.

Credit: ABC Action News    Duration: 01:51Published
Economist: Biden's executive orders on Covid-19 are 'critical' for US economy [Video]

Economist: Biden's executive orders on Covid-19 are 'critical' for US economy

Moody’s Analytics Chief Economist Mark Zandi discusses why he believes Biden’s executive orders on the covid-19 response will bring the economy back up to speed.

Credit: Bleacher Report AOL    Duration: 03:18Published

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Expert panel recommends permission for phase 1 clinical trial of Bharat Biotech's nasal vaccine

An expert panel of India's drug regulator CDSCO on Tuesday recommended granting permission for conducting phase 1 clinical trial of an intranasal vaccine against..
IndiaTimes

Centre issues Letter of Comfort to Bharat Biotech for 45 lakh doses of Covaxin

Bharat Biotech has secured a fresh Letter of Comfort from the Centre for another 45 lakh doses of its COVID-19 vaccine, Covaxin, sources said. ​​Out of the..
IndiaTimes

COVID-19: Who shouldn't take Covaxin? Bharat Biotech releases factsheet as concerns grow

Bharat Biotech issued the factsheet just two days after the launch of vaccination drive in the country.
DNA

Related videos from verified sources

Covaxin's immunity will address mutants too: ICMR scientist [Video]

Covaxin's immunity will address mutants too: ICMR scientist

Indian Council of Medical Research, Scientist and Head of Epidemiology and Communicable Diseases Division, Dr. Samiran Panda said that the immunity produced by the Covaxin is expected to address the..

Credit: ANI     Duration: 01:24Published